World's Best Scientists 2026 revealed!
Geert Verleden

Geert Verleden

D-Index & Metrics

Medicine

D-Index
85
Citations
28480
World Ranking
14539
National Ranking
182

Overview

Geert Verleden is affiliated with KU Leuven in Belgium and has contributed extensively to medical research, particularly in the field of transplantation and pulmonary medicine. Their research has a strong focus on the survival and outcomes related to organ transplantation, alongside studies on interstitial lung diseases and idiopathic pulmonary fibrosis.

The main fields of study for this researcher include:

  • Medicine

Within these, notable subfields cover:

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Epidemiology
  • Transplantation
  • Biomedical Engineering

The scientific output emphasizes topics such as:

  • Transplantation: Methods and Outcomes
  • Organ Transplantation Techniques and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Mechanical Circulatory Support Devices
  • Renal Transplantation Outcomes and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Polyomavirus and related diseases

Geert Verleden has published in prominent journals, with frequent contributions to:

  • The Journal of Heart and Lung Transplantation
  • American Journal of Transplantation
  • European Respiratory Journal
  • Transplantation
  • Transplant International

Notable recent papers include:

  • "Survival in adult lung transplantation: where are we in 2020?" (2020) published in Current Opinion in Organ Transplantation
  • "Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study" (2020) published in The Lancet Respiratory Medicine
  • "Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study" (2020) published in European Respiratory Journal
  • "Small airway loss in the physiologically ageing lung: a cross-sectional study in unused donor lungs" (2020) published in The Lancet Respiratory Medicine
  • "Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions" (2022) published in ERJ Open Research

Frequent collaborators in their research include Robin Vos, Dirk Van Raemdonck, Laurens J. Ceulemans, Bart Vanaudenaerde, and Stijn E. Verleden. These coauthors have appeared numerous times alongside Geert Verleden, indicating sustained joint work across various projects.

Best Publications

  • A consensus document for the selection of lung transplant candidates: 2014-An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

    David Weill;Christian Benden;Paul A. Corris;John H. Dark

  • Azithromycin: mechanisms of action and their relevance for clinical applications.

    Michael J. Parnham;Michael J. Parnham;Vesna Erakovic Haber;Evangelos J. Giamarellos-Bourboulis;Gianpaolo Perletti;Gianpaolo Perletti

  • Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT

    Geert M. Verleden;Allan R. Glanville;Erika D. Lease;Andrew J. Fisher

  • Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

    Guy G Brusselle;Christine VanderStichele;Paul Jordens;René Deman

  • A new classification system for chronic lung allograft dysfunction

    Geert M. Verleden;Ganesh Raghu;Keith C. Meyer;Allan R. Glanville

  • An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

    Keith C. Meyer;Ganesh Raghu;Geert M. Verleden;Paul A. Corris

  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation

    Deborah J. Levine;Allan R. Glanville;Christina Aboyoun;John Belperio

  • Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome

    Geert M. Verleden;Bart M. Vanaudenaerde;Lieven J. Dupont;Dirk E. Van Raemdonck

  • The pathogenesis of pulmonary fibrosis: a moving target

    Wim A Wuyts;Carlo Agostini;Katerina M Antoniou;Demosthenes Bouros

  • Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease.

    Ingel K. Demedts;Ken R. Bracke;Geert Van Pottelberge;Dries Testelmans

  • Tracheal allotransplantation after withdrawal of immunosuppressive therapy

    Pierre Delaere;Jan Vranckx;Geert Verleden;Paul De Leyn

  • Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection

    K Blondeau;V Mertens;B A Vanaudenaerde;G M Verleden

  • Prospective Evaluation of the Validity of Exhaled Nitric Oxide for the Diagnosis of Asthma

    Lieven J. Dupont;Maurits G. Demedts;Geert M. Verleden

  • Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening.

    Fabienne Dobbels;Johan Vanhaecke;Lieven Dupont;Frederik Nevens

  • Exhaled Nitric Oxide Correlates with Airway Hyperresponsiveness in Steroid-naive Patients with Mild Asthma

    Lieven J. Dupont;Felicien Rochette;Maurits G. Demedts;Geert M. Verleden

  • A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation

    R Vos;B M Vanaudenaerde;S E Verleden;S I De Vleeschauwer

  • An official American Thoracic Society/European Respiratory Society statement: research questions in COPD

    Bartolome R. Celli;Marc Decramer;Jadwiga A. Wedzicha;Kevin C. Wilson

  • Lung Donor Selection and Management

    Dirk Van Raemdonck;Arne Neyrinck;Geert M Verleden;Lieven Dupont

  • Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers.

    Marc de Perrot;Robert S. Bonser;John Dark;Rosemary F. Kelly

  • Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT.

    Allan R. Glanville;Geert M. Verleden;Jamie L. Todd;Christian Benden

Frequent Co-Authors

Lieven Dupont
Lieven Dupont KU Leuven
Marc Decramer
Marc Decramer KU Leuven
Daniel Sifrim
Daniel Sifrim Queen Mary University of London
Tim S. Nawrot
Tim S. Nawrot Hasselt University
Wim Wuyts
Wim Wuyts University of Antwerp

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens doors to diverse educational options and professional avenues. If you are exploring allied health or administrative roles, healthcare administration programs online let you develop critical management skills while balancing work and study. These programs prepare graduates for leadership roles in hospitals, clinics, and healthcare organizations.

For nurses aiming to advance their clinical expertise, transitioning through asn to fnp programs is a popular path. These bridge programs allow ADN-qualified nurses to earn a master’s and become Family Nurse Practitioners, opening the door to higher earning potential and expanded clinical responsibilities.

Students interested in diet and wellness can pursue an online degree in nutrition, a growing field that blends scientific knowledge with practical skills to help people lead healthier lives. This degree can lead to careers in dietetics, health coaching, and more.

If you’re a working professional, you might be asking, whats the best online mha program for working adults? These flexible, accredited programs are designed for those balancing a career, offering advanced leadership training and expanding opportunities in healthcare management.

Best Scientists Citing Geert Verleden

Trending Scientists